ioflupane i 123
Generic: ioflupane i-123
Labeler: curium us llcDrug Facts
Product Profile
Brand Name
ioflupane i 123
Generic Name
ioflupane i-123
Labeler
curium us llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
ioflupane i-123 2 mCi/mL
Manufacturer
Identifiers & Regulatory
Product NDC
69945-166
Product ID
69945-166_c6a56613-3636-4736-bdaf-db89d8a8448b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA213792
Listing Expiration
2026-12-31
Marketing Start
2022-03-31
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
69945166
Hyphenated Format
69945-166
Supplemental Identifiers
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ioflupane i 123 (source: ndc)
Generic Name
ioflupane i-123 (source: ndc)
Application Number
ANDA213792 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mCi/mL
Packaging
- 2.5 mL in 1 VIAL, SINGLE-DOSE (69945-166-05)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "c6a56613-3636-4736-bdaf-db89d8a8448b", "openfda": {"nui": ["N0000177914", "N0000000205"], "unii": ["3MM99T8R5Q"], "spl_set_id": ["66d20aee-4530-48dd-a483-ed7604b36d97"], "pharm_class_epc": ["Radioactive Diagnostic Agent [EPC]"], "pharm_class_moa": ["Radiopharmaceutical Activity [MoA]"], "manufacturer_name": ["Curium US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2.5 mL in 1 VIAL, SINGLE-DOSE (69945-166-05)", "package_ndc": "69945-166-05", "marketing_start_date": "20220331"}], "brand_name": "Ioflupane I 123", "product_id": "69945-166_c6a56613-3636-4736-bdaf-db89d8a8448b", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Radioactive Diagnostic Agent [EPC]", "Radiopharmaceutical Activity [MoA]"], "product_ndc": "69945-166", "generic_name": "IOFLUPANE I-123", "labeler_name": "Curium US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ioflupane I 123", "active_ingredients": [{"name": "IOFLUPANE I-123", "strength": "2 mCi/mL"}], "application_number": "ANDA213792", "marketing_category": "ANDA", "marketing_start_date": "20220331", "listing_expiration_date": "20261231"}